Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-02-20 @ 4:46 PM
Study NCT ID:
NCT03494569
Status:
RECRUITING
Last Update Posted:
2025-11-07
First Post:
2018-04-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome
Sponsor:
City of Hope Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-06
Start Date Type:
ACTUAL
Primary Completion Date:
2026-09-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-09-08
Completion Date Type:
ESTIMATED
First Submit Date:
2018-04-04
First Submit QC Date:
None
Study First Post Date:
2018-04-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-06
Last Update Post Date:
2025-11-07
Last Update Post Date Type:
ESTIMATED